REAL-WORLD USE OF SOLRIAMFETOL FOR EXCESSIVE DAYTIME SLEEPINESS IN PATIENTS REPORTING ANXIETY OR DEPRESSION

Authors
Category Primary study
JournalSleep
Year 2024
This article has no abstract
Epistemonikos ID: ac294377cb4330ba883d16b7e23ab2722096674f
First added on: Feb 17, 2025